Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus
J. Clin. Invest. Utako Yokoyama, et al. 116:3026
doi:10.1172/JCI28639 [Go to this article.]

Figure 3
HA production is mediated by PGE/EP4/PKA signal in DA SMCs. (A) HA production after 48-hour stimulation with agents. PGE1, PGE2, and ONO-AE1-329 at 10–6 M dramatically increased HA production in the DA but not in the aorta. ONO-AE3-208 (10–6 M), an EP4 antagonist, almost abolished the effect of PGE1 (10–6 M). The ONO-AE1-329–induced HA production was significantly attenuated by transfection with rat HAS2 siRNA (100 pmol) or H89. Forskolin (10–5 M) and pCPT-cAMP (10–4 M) significantly increased HA production in both the DA and aortic SMCs. Sulprostone (10–6 M), an EP1/3-selective agonist, and butaprost (10–6 M), an EP2-selective agonist, had little effect on HA secretion in DA SMCs. TGF-β (10 ng/ml) and PDGF-BB (10 ng/ml) significantly increased HA production in the aorta but not in the DA. n = 4–8; **P < 0.01, #P < 0.001 compared with control. P < 0.05, ††P < 0.01, ΧP < 0.001 compared with aorta. (B) Dose-dependent HA production after 48-hour stimulation with ONO-AE1-329. (C) Time-dependent HA production stimulated by 10–6 M ONO-AE1-329. n = 4; **P < 0.01, #P < 0.001 compared with control. ND, not done.